市场调查报告书
商品编码
1166579
临床试验管理服务的全球市场 - 产业规模,占有率,趋势,机会,预测:各服务形式,各业界,各适应症,各企业,各地区(2017年~2027年)Clinical Trials Management Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Service Type, By Industry, By Indication, By Company and By Region |
全球临床试验管理服务市场,预计从2023年到2027年的预测期间内完成惊人的成长。
主要原因,包含各种疾病的发生率增加,个人化医疗的需求高涨,技术广泛的开发,促进市场成长。支撑市场成长的其他的因素,是广泛的研究开发,各种与生命相关疾病的盛行率,多数的临床试验研究调查,对疫苗接种与医药品的庞大需求,人口高龄化的发展,製药公司和生物科技企业的研究开发活动的投资增加等。还有由于慢性疾病与其他的文明病增加,全球市场成长加速。
本报告提供全球临床试验管理服务市场相关调查,各市场区隔分析,市场动态,企业简介等资讯。
The global clinical trials management services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases, upsurge demand for personalized medicines, and extensive development in technology, are curbing the market's growth. A clinical trial is a process in which several experiments or studies are performed on animals and humans to examine the results. Clinical trials are divided into two types that is observational studies and interventional trials. The other factors supporting the market's growth are, the extensive research and development, prevalence of various life-related diseases, large number of clinical trials and research studies, huge demand for vaccinations and medications, the growing aging population, and rise in investments by pharmaceutical and biotechnology companies in research and development activities.
Increasing Prevalence of Chronic and Lifestyle-Related Disorders
The growing occurrences of chronic diseases and other lifestyle-based diseases among population are augmenting the growth of the market, globally. Nowadays, people are opting for unhealthy choices such as tobacco, smoking, consumption of junk foods and others, due to which they suffer from various chronic diseases such as diabetes, heart strokes, hypertension, blood pressure and other. As per the national health survey, between 2017-2018, approximately 28.8% of adults in the UAE have high blood pressure. Owing to the increasing prevalence of these chronic diseases and growing demand for effective treatment methods, the surge in demand for development of innovative drugs is propelling the growth of the market, globally.
Rise in R&D Activities
Rising research and development activities for novel and personalized medications are propelling the growth of the market. Increasing investments in R&D activities such as by governments and key market players are strengthening the growth of the market. For instance, according to WHO, in 2020, 147,213 trials took place in the United States, then 23,051 trials in China and 13,481 in Japan.
Growing Demand for Precision Medicines
Growing prominence of specialized medicines is one of the primary factors, supporting the growth of the market. The surging demand for personalized medicines is due to their efficiency to treat unique, yet complex diseases. Doctors, researchers, and pharmaceutical firms are using precision medicine to develop new drugs and disease therapies, which surge the demand for clinical trial management services. For instance, in 2020, according to scope and significance of progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year.
Technological Advancements
Rapid advancements in tools and techniques are curbing the growth of the market. The increasing adoption of advanced technology such as AI, cloud based clinical trials, and machine learning in healthcare sector is driving the growth of the market. For instance, in South Korea, Asan Medical Center (AMC) has developed a new system, capable of handling clinical trial image data from group to extraction. This is expected to be a major revolution in CTM systems, as this could make clinical trials more effective and speedier than ever before. Similarly, as per the Veeva Unified Clinical Operations Survey, CROs are making major advancements to speed up and modernize clinical trials.
Market Segmentation
The global clinical trials management services market is segmented into service type, industry, indication, and company. Based on service type, the market is segmented into clinical trial monitoring, regulatory submissions, clinical trial data management, site management & monitoring, and others. Based on industry, the market is segmented into medical devices, and pharmaceuticals. Based on indication, the market is divided into immunology, hematology, oncology, neurology, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising occurrences in chronic diseases and extensive technology development in the country.
Market Players
Laboratory Corporation of America Holdings, SGS Health Sciences, IQVIA, Inc., Syneous Health, Inc., Atlantic Research Group, ICON PLC, Charles River Laboratories International, Inc., and Medpace Holdings, Inc. are some of the leading companies operating in the market.
Report Scope:
In this report, global clinical trials management services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Clinical Trial Monitoring
Regulatory Submissions
Clinical Trial Data Management
Site Management & Monitoring
Others
Medical Devices
Pharmaceuticals
Immunology
Hematology
Oncology
Neurology
Others
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
Australia
South Korea
Europe & CIS
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Clinical Trials Management Services Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information